Freelance science and health journalist with lots of experience writing about all aspects of life sciences and biotech. Recovering geneticist and evolutionary biologist. I am half German and half British and spend most of my time in Berlin while not hiding out in the Norfolk countryside in the UK. When not writing or editing, I like to spend my time taking photos, knitting, reading fiction, eating and making good food and travelling (when global conditions allow!).

Articles by Helen Albert

In Depth 25 May 2020

Could Cell Therapy Target the Symptoms of Severe Covid-19?

Phase II Success for Once-a-Day Eye Drops after Cataract Surgery

In Depth 18 May 2020

Will Covid-19 Change the Face of Vaccine Development?

Genfit’s Phase III Drug Fails to Treat NASH, But New Players On Horizon

Italian Pharma Getting Back to Normal With Two Biotech Acquisitions

BioMarin Partners Swiss Biotech to Develop Cardiac Gene Therapies

Expert Advice 4 May 2020

How Are Biotech VC Investments Changing with Covid-19?

Update: BioNTech and Pfizer’s mRNA Vaccine for Covid-19 Tested in Humans

Pluristem Scores €50M From EIB to Develop Covid-19 Cell Therapy

Is New Enzyme Technology Key to Solving Society’s Plastic Problem?

Evotec Makes Move into Gene Therapy with Takeda Deal

Lilly Partners UK Immunometabolism Biotech in Deal Worth €811M